Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Risperidone and Aripiprazole on Irritability and Serotonin in Children with Autism Spectrum Disorder
TCTR20250217004Phase 3Completed
- Sponsor
- N/A
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of risperidone, aripiprazole in Autism Spectrum Disorder (ASD), sponsored by N/A. Started Sep 2022; status: completed.
02
Drugs
risperidonearipiprazole
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on TCTR20250217004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250217004.